Cerenia Vomiting Med Approved For Use In Cats, Younger Dogs

The U.S. Food and Drug Administration has approved a label update for Cerenia Injectable Solution.

The U.S. Food and Drug Administration has approved a label update for Cerenia (maropitant citrate) Injectable Solution, a veterinary antiemetic drug, to include the treatment of vomiting in cats older than 16 weeks, according to Pfizer Animal Health, the drug’s maker.

In addition, the new label lowers the recommended age of use in dogs from 16 weeks to 8 weeks for the prevention and treatment of acute vomiting in dogs for both the injectable and tablet form of Cerenia, which was first approved in the United States in 2007.

The injectable solution is generally uses to treat vomiting at the practice while the tablets are designed for home use. Cerenia tablets are also approved for the use of prevention of vomited due to motion sickness in dogs older than 16 weeks.

“Because of the positive results of Cerenia and its importance among veterinary professionals and pet owners, Pfizer Animal Health was committed to providing the science to support this label update so that cats and younger puppies may also be effectively treated for vomiting,” said J. Michael McFarland, DVM, Dipl. ABVP, group director of veterinary operations for the companion animal division of Pfizer Animal Health.

<HOME>

Leave a Comment

Comments

Your email address will not be published. Required fields are marked *

___

Register

Sign-up for your account with Veterinary Practice News. Your account gives you unlimited free access to our Newsletter Archives and our Digital Editions of Veterinary Practice News.
Please check the box below to confirm you would like to be added to Kenilworth Media’s various e-mail communications (includes e-newsletters, a survey now and then, and offers to the veterinarian industry*).
 

Leave this empty:

*We do not sell your e-mail address to 3rd parties, we simply forward their offers to you. Of course, you always have the right to unsubscribe from any communications you receive from us, should you change your mind in the future.